StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.99−0.41 (-2.85%)

Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –

HUTCHMED (China) revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

HUTCHMED (China)'s revenue for the twelve months ending Dec 31, 2019 was $204.89M, down 4.3% year over year. For fiscal 2025 it was $548.51M, down 13.0% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $838.00M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$548.51M-13.0%
FY2024Dec 31, 2024$630.20M-24.8%
FY2023Dec 31, 2023$838.00M+96.5%
FY2022Dec 31, 2022$426.41M+19.7%
FY2021Dec 31, 2021$356.13M+56.2%
FY2020Dec 31, 2020$227.98M+11.3%
FY2019Dec 31, 2019$204.89M-4.3%
FY2018Dec 31, 2018$214.11M-11.2%
FY2017Dec 31, 2017$241.20M+11.6%
FY2016Dec 31, 2016$216.08M+21.3%
FY2015Dec 31, 2015$178.20M+104.1%
FY2014Dec 31, 2014$87.33M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$53.34M+0.4%
Q3 FY2019Sep 30, 2019$49.35M-16.1%
Q2 FY2019Jun 30, 2019$50.03M+0.4%
Q1 FY2019Mar 31, 2019$52.17M-0.3%
Q4 FY2018Dec 31, 2018$53.11M–
Q3 FY2018Sep 30, 2018$58.81M–
Q2 FY2018Jun 30, 2018$49.85M–
Q1 FY2018Mar 31, 2018$52.34M–

More HUTCHMED (China) figures

See a number that looks wrong?